Search Tips

Simulation Results: Survival Impact of Treatment and Imaging Modalities for 11 Cancers in 200 Countries

UID: 11067

Author(s): Ward, Zachary J., Scott, Andrew, Hricak, Hedvig*, Abdel-Wahab, May, Paez, Diana, Lette, Miriam Mikhail, Vargas Alvarez, Hebert Alberto*, Kingham, T. Peter*, Atun, Rifat * MSK affiliated

Description
Simulation results (means and 95% uncertainty intervals) for 11 cancer sites, 4 cancer stages, and 5 age groups. Includes survival estimates for cancer control planning across 200 countries. Data estimates the 5-year net survival for diagnosed cancers in each country or territory and estimated potential survival gains from increasing the availability of individual treatment and imaging modalities, and more comprehensive packages of scale-up of these interventions.
Subject of Study
Homo sapiens
Subject(s)
Models, Statistical
Neoplasms/diagnostic imaging
Survival Analysis
Access via Harvard Dataverse

Access Restrictions
Free to All
Access Instructions
Downloads available through Harvard Dataverse on a CC0 1.0 license
DOI
10.7910/DVN/C7WE5L
Associated Publications
Ward Z, Scott A, Hricak H, Abdel-Wahab M, Paez D, Lette M, Vargas H, Kingham T, Atun R. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: A simulation-based analysis. Lancet Oncology. 2020; 21(8):1077-1088.
Software Used
SEER*Stat
Dataset Format(s)
TAB, TXT
Dataset Size
4.9 KB (TXT), 346.6 KB (TAB), 482.9 KB (TAB), 429.0 KB (TAB)
Data Catalog Record Updated
2023-11-29